Product Information
REPAGLINIDE 0.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0761 per EA under NDC 57237015701. Its NADAC has been published 506 times since Oct 19, 2016.
Strength
.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237015701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203820On Market Since
1/22/2014
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 0.5 MG TABLET has been published 506 times since Oct 19, 2016, and over the history we have for it it has declined 72.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0761 per EA |
|---|---|
| All-time high | $0.2919 (Nov 15, 2017) |
| All-time low | $0.0723 (Dec 17, 2025) |
| 52-week high | $0.0890 |
| 52-week low | $0.0723 |
| Median price | $0.1545 |
| Average price | $0.1545 |
| Largest weekly change | +42.8% (Sep 22, 2021) |
| Weeks tracked | 506 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPAGLINIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 0.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0761 per EA (NDC 57237015701), effective Jun 24, 2026.
How has the price of REPAGLINIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 0.5 MG TABLET has declined 72.1%. It has been tracked across 506 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 0.5 MG TABLET?
Since Oct 19, 2016, the NADAC for REPAGLINIDE 0.5 MG TABLET has ranged from a low of $0.0723 (Dec 17, 2025) to a high of $0.2919 (Nov 15, 2017), with a median of $0.1545 per EA.
Are there cheaper alternatives to REPAGLINIDE 0.5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as REPAGLINIDE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures REPAGLINIDE 0.5 MG TABLET?
REPAGLINIDE 0.5 MG TABLET (NDC 57237015701) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification